Nasdaq-listed Windtree Therapeutics unveils new funding plans to generate $520 million. Most of the funds will be used to accelerate the firm’s BNB treasury strategy. According to a recent press release, the Nasdaq-listed biotechnology company announced that it has signed…
Related Posts
Privado ID spinoff takes identity control solution beyond Polygon
Polygon’s zero-knowledge self-sovereign identity solution looks to provide privacy with assured authenticity.
Pi crypto news update: Pi price up 5% ahead of June 28 major update
After a brutal 70% plunge from May highs, PI claws back 5% as the Core Team hints at…
MetaMask denies claims of wallet exploit in ‘massive’ $10M hack
MetaMask stated its security team is working with others in the Web3 wallet space to uncover the source…